Industry Cost Estimates For Proposed Consumer Antiseptic Rule Dwarf FDA’s
This article was originally published in The Tan Sheet
The Personal Care Products Council and American Cleaning Institute challenge FDA cost projections and question the agency’s proposal for clinical studies data to back the efficacy of antibacterial hand-wash products. The groups say manufacturers require guidance and request an extension of the deadline for data submissions, currently December 2014.
You may also be interested in...
FDA proposes to amend the OTC antiseptic drug product monograph to require more detailed safety and efficacy tests, pointing to mounting data that shows antibacterial wash products could pose health risks and contribute to increase antibacterial resistance.
Tom's natural claims on toothpastes and deodorants are false and misleading, a plaintiff alleges in a proposed class action filed in Massachusetts federal court. Similar to previous complaints against Colgate/Tom’s, the plaintiff’s case is premised on the contention that “natural,” as opposed to “100% natural,” means no synthetic ingredients.